Evaro
PrivateLast Round
Series A
Jan 27, 2026
Total Funding Raised
$26.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Evaro operates in Healthcare & Life Sciences and is based in Norwich. Its latest recorded funding round was a Series A round in January 2026.
Evaro is a healthcare technology company that provides a B2B pharmaceutical infrastructure-as-a-service platform, enabling consumer brands to seamlessly integrate prescription medication services into their offerings.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, API Management, Patient Engagement, Workflow Automation, Compliance
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evaro Comparables
Compare Evaro with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kry | 71% | |
| Semble | 71% | |
| Modality Partnership | 71% |
For institutional investors. Book with your work email.
Evaro Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 27, 2026 | ||||
| Seed | Jan 31, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Evaro Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Simplyhealth Ventures | Series A |
| University of East Anglia | Seed |
| Exceptional Ventures | Series A, Seed |
| Catalisi | Seed |
| Cornerstone VC | Series A, Seed |
| Albion Capital | Series A |
| British Business Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 27, 2026
$25M round completed.
- Jan 27, 2026
Christoph Ruedig joins the board of directors.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 16, 2026
Evaro launches The Online Prescription Services for all Simplyhealth members on Oct 16th '26, offering free online consultations, clinician-reviewed prescriptions and discreet medication delivery.
For institutional investors. Book with your work email.
Evaro Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Evaro's valuation, stock price, and market status.
Is Evaro a public or private company?
Evaro is a private company.
What is the current stock price of Evaro?
Evaro is a private company, so its shares have no public market price. Caplight tracks Evaro's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Evaro worth (valuation)?
Valuation information for Evaro is not publicly available.
Can I buy Evaro stock?
Evaro shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Evaro's last funding round?
Evaro's most recent funding round was Series A on January 27, 2026.
Who are the main investors in Evaro?
Key investors in Evaro include Exceptional Ventures, Cornerstone VC, Albion Capital.
Will Evaro IPO soon?
No public IPO plans have been announced for Evaro.
How can I track Evaro secondary market activity?
Caplight tracks bids, offers, and trades in Evaro's shares on secondary markets.